- Home
- ACFN vs CNTX Comparison
ACFN vs CNTX Comparison
Compare ACFN & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- CNTX
- Stock Information
- Founded
- ACFN 1986
- CNTX 2015
- Country
- ACFN United States
- CNTX United States
- Employees
- ACFN N/A
- CNTX N/A
- Industry
- ACFN Military/Government/Technical
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- CNTX Health Care
- Exchange
- ACFN Nasdaq
- CNTX Nasdaq
- Market Cap
- ACFN 76.5M
- CNTX 75.6M
- IPO Year
- ACFN N/A
- CNTX 2021
- Fundamental
- Price
- ACFN $29.77
- CNTX $0.84
- Analyst Decision
- ACFN
- CNTX Strong Buy
- Analyst Count
- ACFN 0
- CNTX 5
- Target Price
- ACFN N/A
- CNTX $5.25
- AVG Volume (30 Days)
- ACFN 25.8K
- CNTX 151.3K
- Earning Date
- ACFN 11-06-2025
- CNTX 11-05-2025
- Dividend Yield
- ACFN N/A
- CNTX N/A
- EPS Growth
- ACFN 1520.82
- CNTX N/A
- EPS
- ACFN 2.84
- CNTX N/A
- Revenue
- ACFN $13,202,000.00
- CNTX N/A
- Revenue This Year
- ACFN N/A
- CNTX N/A
- Revenue Next Year
- ACFN N/A
- CNTX N/A
- P/E Ratio
- ACFN $10.50
- CNTX N/A
- Revenue Growth
- ACFN 50.98
- CNTX N/A
- 52 Week Low
- ACFN $17.22
- CNTX $0.49
- 52 Week High
- ACFN $33.00
- CNTX $2.59
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- CNTX 53.79
- Support Level
- ACFN N/A
- CNTX $0.81
- Resistance Level
- ACFN N/A
- CNTX $0.89
- Average True Range (ATR)
- ACFN 0.00
- CNTX 0.05
- MACD
- ACFN 0.00
- CNTX -0.01
- Stochastic Oscillator
- ACFN 0.00
- CNTX 25.00
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.